OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

IL-6 and IL-8 are involved in JMJD2A-regulated malignancy of ovarian cancer cells
Haiyu Zhang, Zichao Wang, Fengxia Wang, et al.
Archives of Biochemistry and Biophysics (2020) Vol. 684, pp. 108334-108334
Closed Access | Times Cited: 18

Showing 18 citing articles:

Interleukin-6 serves as a critical factor in various cancer progression and therapy
Asma’a H. Mohamed, Abdulrahman T. Ahmed, Waleed Al Abdulmonem, et al.
Medical Oncology (2024) Vol. 41, Iss. 7
Closed Access | Times Cited: 13

An evaluation of inflammatory and endothelial dysfunction markers as determinants of peripheral arterial disease in those with diabetes mellitus
Sumera Zaib, Shabbir Ahmad, Imtiaz Khan, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6

The implication of IL-6 in the invasiveness and chemoresistance of ovarian cancer cells. Systematic review of its potential role as a biomarker in ovarian cancer patients
Izabela Szulc-Kiełbik, Michał Kiełbik, Marek Nowak, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2021) Vol. 1876, Iss. 2, pp. 188639-188639
Open Access | Times Cited: 34

microRNA-216b enhances cisplatin-induced apoptosis in osteosarcoma MG63 and SaOS-2 cells by binding to JMJD2C and regulating the HIF1α/HES1 signaling axis
Yang Dong, Tian-Yang Xu, Lin Fan, et al.
Journal of Experimental & Clinical Cancer Research (2020) Vol. 39, Iss. 1
Open Access | Times Cited: 28

The potential role of interleukins and interferons in ovarian cancer
Huldani Huldani, Sana Ali, F. Al-dolaimy, et al.
Cytokine (2023) Vol. 171, pp. 156379-156379
Closed Access | Times Cited: 8

Astrocyte KDM4A mediates chemokines and drives neutrophil infiltration to aggravate cerebral ischemia and reperfusion injury
Jing Huang, Xin‐shang Wang, Tian Gao, et al.
Journal of Cerebral Blood Flow & Metabolism (2023) Vol. 44, Iss. 4, pp. 491-507
Closed Access | Times Cited: 7

Correction to: microRNA-216b enhances cisplatin-induced apoptosis in osteosarcoma MG63 and SaOS-2 cells by binding to JMJD2C and regulating the HIF1α/HES1 signaling axis
Dong Yang, Tianyang Xu, Lin Fan, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 15

JMJD2C mediates the MDM2/p53/IL5RA axis to promote CDDP resistance in uveal melanoma
Qi Zhu, Han Chen, M Kellis, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 11

IL-6 Accelerates the Proliferation and Metastasis of Pancreatic Cancer Cells via the miR-455-5p/IGF-1R Axis
Yuting Zhang, Huan He, Lanying He, et al.
Cancer Biotherapy and Radiopharmaceuticals (2023) Vol. 39, Iss. 4, pp. 255-263
Closed Access | Times Cited: 5

Prognostic and Clinical Value of Interleukin 6 and CD45+CD14+ Inflammatory Cells with PD-L1+/PD-L2+ Expression in Patients with Different Manifestation of Ovarian Cancer
Iwona Wertel, Dorota Suszczyk, Anna Pawłowska, et al.
Journal of Immunology Research (2020) Vol. 2020, pp. 1-16
Open Access | Times Cited: 14

Interleukin-6 Modulation in Ovarian Cancer Necessitates a Targeted Strategy: From the Approved to Emerging Therapies
Hina Amer, Nirmala Chandralega Kampan, Catherine Itsiopoulos, et al.
Cancers (2024) Vol. 16, Iss. 24, pp. 4187-4187
Open Access | Times Cited: 1

Investigation of the Mechanism of hsa_circ_000 1429 Adsorbed miR-205 to Regulate KDM4A and Promote Breast Cancer Metastasis
Yuting Xu, Cheng Qian, Chunxiao Liu, et al.
Contrast Media & Molecular Imaging (2022) Vol. 2022, Iss. 1
Open Access | Times Cited: 4

The role of pro-inflammatory components, carcinoma-associated fibroblasts, and tumor-associated macrophages in ovarian cancer progression and metastasis
Josiany Carlos de Souza, Roberto Ribeiro, Tatiana Pimenta, et al.
Journal of Cancer Metastasis and Treatment (2023)
Open Access | Times Cited: 2

Systemic Inflammatory Patterns in Ovarian Cancer Patients: Analysis of Cytokines, Chemokines, and Microparticles
Aline Evangelista Santiago, Sálua Oliveira Calil de Paula, Andréa Teixeira−Carvalho, et al.
Revista Brasileira Ginecologia e Obstetrícia (2023) Vol. 45, Iss. 12, pp. e780-e789
Open Access | Times Cited: 2

Comprehensive analyses of fatty acid metabolism-related lncRNA for ovarian cancer patients
Min Li, Ye Yan, Yanyan Liu, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 1

Engineering human JMJD2A tudor domains for an improved understanding of histone peptide recognition
Jonathan Parkinson, Ryan Hard, Richard I. Ainsworth, et al.
Proteins Structure Function and Bioinformatics (2022) Vol. 91, Iss. 1, pp. 32-46
Open Access

Page 1

Scroll to top